Zobrazeno 1 - 10
of 451
pro vyhledávání: '"uterine cervix cancer"'
Autor:
Sebastián Aguiar-Rosas, Ricardo Plancarte-Sanchez, B. Carolina Hernandez-Porras, Jorge García-Andreu, Brenda Olivia Lezcano-Velazquez, Ignacio Reyes-Torres, Silvia Alarcón-Barrios
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Cervical cancer (CC) occupies the second place in incidence and mortality among women in México. Despite this, Cervical Cancer continues to have a late diagnosis which leads to a high rate of complications. Pain represents the most feared and disabl
Externí odkaz:
https://doaj.org/article/04a787345f164d52b07b989616415ee6
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background CXCL1 belongs to a member of the ELR + CXC chemokine subgroups that also known as GRO-alpha. It has been recognized that several types of human cancers constitutively express CXCL1, which may serve as a crucial mediator involved i
Externí odkaz:
https://doaj.org/article/004fc19f060c4729b7ec8a0b09b5953c
Autor:
Charles A. Kunos, Denise Fabian, Dana Napier, Mark S. Stonecypher, Ravyn M. Duncan, Jason Hurt
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Introduction212Pb-DOTAM-GRPR1 is a pharmaceutical radioimmunoconjugate consisiting of an α-particle-emitting radionuclide lead-212 (212Pb), a metal chelator DOTAM (1,4,7,10-tetrakis(carbamoylmethyl)-1,4,7,10-tetraazacyclododecane), and a gastrin-rel
Externí odkaz:
https://doaj.org/article/1f994eafa50845afadb2184a8dcfdccb
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 16, Iss 3, Pp AC01-AC04 (2022)
Introduction: Cervix cancer is most prevalent cancer in females. Early detection and regular screening methods are helpful for the prevention of cervix cancer related morbidity and mortality. Early stages of development, dermatoglyphic features are g
Externí odkaz:
https://doaj.org/article/0f95166212914dd98c0a53629c883b93
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Uterine cervix or vaginal cancers have inherent overactivity of ribonucleotide reductase (RNR), making these cancers rational targets for therapy based on interruption of cisplatin-radiotherapy-induced DNA damage repair. We conducted a pilot, open-la
Externí odkaz:
https://doaj.org/article/751c5d6582154f6080b4693151e82a43
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Uterine cervix cancers pose therapeutic challenges because of an overactive ribonucleotide reductase, which provides on-demand deoxyribonucleotides for DNA replication or for a DNA damage repair response. Ribonucleotide reductase overactivity bestows
Externí odkaz:
https://doaj.org/article/dd37f8c06b684d638595e7669d9eb13e
Autor:
Charles A. Kunos, Percy Ivy
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Evaluating the impact of natural disasters on cancer patients is vital to the recovery of cancer treatment services and infrastructure. In September 2017, Hurricane Maria demolished the gynecologic cancer service in the United States territory of Pue
Externí odkaz:
https://doaj.org/article/c0e87f8d6c6b4f37adfa5cf44597bfd8
Autor:
Charles A. Kunos, S. Percy Ivy
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Clinical ribonucleotide reductase (RNR) inhibitors have reinvigorated enthusiasm for radiochemotherapy treatment of patients with regionally advanced stage cervical cancers. About two-thirds of patients outlive their cervical cancer (1), even though
Externí odkaz:
https://doaj.org/article/8f2f95d88d5b4ef691c1e59acbc31624
Autor:
Charles A. Kunos, Holly A. Massett, Annette Galassi, Joan L. Walker, Marge J. Good, Luis Báez Díaz, Worta McCaskill-Stevens
Publikováno v:
Frontiers in Oncology, Vol 8 (2018)
Women in the U.S. Commonwealth of Puerto Rico (PR) have a higher age-adjusted incidence rate for uterine cervix cancer than the U.S. mainland as well as substantial access and economic barriers to cancer care. The National Cancer Institute (NCI) fund
Externí odkaz:
https://doaj.org/article/505d0f03efe043d8b8c4a735f9a18b67
Autor:
N. Nikolov, T. Totev
Publikováno v:
Revmatologiia (Bulgaria). 29:52-58
Връзката между системните автоимунни заболявания, засягащи жените в репродуктив- на възраст, и неоплазмите на долния генитален тракт, п
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dde98430ef672c102b98cda3d9b7da8b
https://doi.org/10.35465/29.1.2021.pp52-58
https://doi.org/10.35465/29.1.2021.pp52-58